Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination

Documenti analoghi

• Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination
  di: Toshihiro Takahashi, et al.
  Pubblicazione: (2023-01-01)
• Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
  di: Maika Takahashi, et al.
  Pubblicazione: (2022-09-01)
• Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment.
  di: Maika Takahashi, et al.
  Pubblicazione: (2023-01-01)
• Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment
  di: Maika Takahashi, et al.
  Pubblicazione: (2023-01-01)
• Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment.
  di: Satomi Takei, et al.
  Pubblicazione: (2022-01-01)